Published: Guidance, quality standards and advice
Showing 1 to 3 of 3
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis | ES35 | ||
| Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis | ES29 | ||
| Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) | ESNM64 |